Does ADALIMUMAB Cause Basal cell carcinoma? 1,547 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,547 reports of Basal cell carcinoma have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.3% of all adverse event reports for ADALIMUMAB.
1,547
Reports of Basal cell carcinoma with ADALIMUMAB
0.3%
of all ADALIMUMAB reports
9
Deaths
760
Hospitalizations
How Dangerous Is Basal cell carcinoma From ADALIMUMAB?
Of the 1,547 reports, 9 (0.6%) resulted in death, 760 (49.1%) required hospitalization, and 33 (2.1%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 1,547 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Basal cell carcinoma?
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which ADALIMUMAB Alternatives Have Lower Basal cell carcinoma Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB